Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00099749 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant
A Phase 2 study, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 255
- Enrollment target
NCT00099749: Completed Phase 2 study, sponsored by Novartis Pharmaceuticals.
NCT00099749 is a Phase 2 study that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 255 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00099749, a Phase 2 study, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 255 participants
- Enrollment target
Study Summary
The efficacy and safety of FTY720 is being evaluated in patients who receive a kidney transplant.
Interventions
- DRUG FTY 720
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2003-11 |
| Phase | Phase 2 |
What the finished NCT00099749 record still lists
NCT00099749 is an interventional study that assigns participants to a tested intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% higher).
The record links to 0 conditions, and to 1 intervention - of which FTY 720 is the first listed.
NCT00099749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00099749 about?
NCT00099749 is a clinical study titled "Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant". The efficacy and safety of FTY720 is being evaluated in patients who receive a kidney transplant.
What is the current status of trial NCT00099749?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 255 participants. The study started on 2003-11.
What interventions are being tested in trial NCT00099749?
The interventions under investigation include: FTY 720 (DRUG).
Who is sponsoring clinical trial NCT00099749?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00099749's enrollment target sits among peer trials
255 218th of 2000 higher than 1,782 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05114798 · 255 participants · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05486637 · 255 participants · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia